與「Franco Franceschini」相符的使用者個人學術檔案

Franco Franceschini

professor of Rheumatology
在 unibs.it 的電子郵件地址已通過驗證
被引用 11953 次

Risk of congenital complete heart block in newborns of mothers with anti‐Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 …

A Brucato, M Frassi, F Franceschini… - Arthritis & …, 2001 - Wiley Online Library
Objective. To assess the true prevalence of con-genital complete heart block (CCHB) in
infants of anti-Ro/SSA–positive women known to have connective tissue disease (CTD) and, …

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in …

…, E Garrafa, F Regola, F Castelli, F Franceschini… - Autoimmunity …, 2020 - Elsevier
Franco Franceschini a e , Paolo Airò a , Chiara Bazzani a , Eva-Andrea Beindorf i , Marialma
Berlendis j , Michela Bezzi k , Nicola Bossini l , Maurizio Castellano e m , Sergio Cattaneo n …

Clinical and morphological features of kidney involvement in primary Sjögren's syndrome

N Bossini, S Savoldi, F Franceschini… - Nephrology Dialysis …, 2001 - academic.oup.com
Background. Primary Sjögren's syndrome is a connective tissue disorder affecting primarily
the lacrimal and salivary glands, resulting in xerophtalmia and xerostomia. Extraglandular …

Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system

…, G Martini, A Tincani, L Andreoli, F Franceschini - Blood reviews, 2021 - Elsevier
COVID-19 is a new pandemic, caused by Severe Acute Respiratory Syndrome-CoronaVirus-2
(SARS-Cov2) infection and characterized by a broad spectrum of clinical manifestations. …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

…, T Ferrari, M Monti, G Elia, F Franceschini… - Journal of …, 2021 - Elsevier
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

…, L Dagna, V Cottin, F Franceschini… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

Novel aspects of Sjögren's syndrome in 2012

…, A Doria, M Favero, MG Fenini, F Franceschini… - BMC medicine, 2013 - Springer
Sjögren’s syndrome (SS) is a systemic progressive autoimmune disease characterized by a
complex pathogenesis requiring a predisposing genetic background and involving immune …

Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's …

…, S De Vita, O Epis, F Franceschini… - … : Official Journal of …, 2007 - Wiley Online Library
Objective. To develop valid instruments for the assessment of disease-related damage and
disease activity in Sjögren’s syndrome (SS). Methods. Data on 206 patients with primary SS …

[HTML][HTML] Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome

…, S Blengino, A Tincani, F Franceschini… - Frontiers in …, 2020 - frontiersin.org
Background Critically ill patients with coronavirus disease 2019 (COVID-19) have a profound
hypercoagulable state and often develop coagulopathy which leads to organ failure and …

Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute …

…, A Tincani, A Brucato, F Franceschini… - Annals of the …, 2020 - ard.bmj.com
Objectives The outbreak of COVID-19 posed the issue of urgently identifying treatment
strategies. Colchicine was considered for this purpose based on well-recognised anti-…